Literature DB >> 23725430

Doxycycline concentration over time after storage in a compounded veterinary preparation.

Mark G Papich1, Gigi S Davidson, Lisa A Fortier.   

Abstract

OBJECTIVE: To determine the concentration of doxycycline compounded from doxycycline hyclate tablets into liquid formulations for oral administration in veterinary species and stored for 28 days.
DESIGN: Evaluation study. SAMPLE: Doxycycline hyclate tablets (100 mg) crushed and mixed with a 50:50 mixture of syrup and suspension vehicles for oral administration to produce 3 batches each of 2 doxycycline formulations: 33.3 and 166.7 mg/mL. PROCEDURES: Formulations were stored, protected from light, at room temperature (22° to 26°C [71.6° to 78.8°F]) and at a controlled cold temperature (refrigerated 2° to 8°C [35.6° to 46.4°F]). Doxycycline was extracted from the formulations, and concentration was measured by high-pressure liquid chromatography on days 0 (date of preparation), 1, 4, 7, 14, 21, and 28. Concentrations were compared with those of a US Pharmacopeial Convention reference standard. Formulation quality at each point was also assessed through color change, formulation consistency, and suspension uniformity.
RESULTS: On days 0, 1, 4, and 7, the concentration of each formulation was within 90% to 110% of the reference standard (range, 93% to 109%), which was deemed acceptable. However, doxycycline concentrations had decreased dramatically by day 14 and remained low for the duration of the study period. Doxycycline concentrations on days 14, 21, and 28 were all < 20% (range, 14% to 18%) of the reference standard, and the quality of the formulations decreased as well. No effect of storage temperatures on doxycycline concentration was identified. CONCLUSIONS AND CLINICAL RELEVANCE: The concentration of doxycycline, compounded from commercial tablets in the vehicles evaluated to yield doses of 33.3 and 166.7 mg/mL, cannot be assured beyond 7 days.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23725430     DOI: 10.2460/javma.242.12.1674

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  4 in total

1.  ACVIM consensus statement on therapeutic antimicrobial use in animals and antimicrobial resistance.

Authors:  J S Weese; S Giguère; L Guardabassi; P S Morley; M Papich; D R Ricciuto; J E Sykes
Journal:  J Vet Intern Med       Date:  2015-03-17       Impact factor: 3.333

2.  Considerations for using minocycline vs doxycycline for treatment of canine heartworm disease.

Authors:  Mark G Papich
Journal:  Parasit Vectors       Date:  2017-11-09       Impact factor: 3.876

3.  Antimicrobial use Guidelines for Treatment of Respiratory Tract Disease in Dogs and Cats: Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases.

Authors:  M R Lappin; J Blondeau; D Boothe; E B Breitschwerdt; L Guardabassi; D H Lloyd; M G Papich; S C Rankin; J E Sykes; J Turnidge; J S Weese
Journal:  J Vet Intern Med       Date:  2017-02-10       Impact factor: 3.333

4.  Fabrication of HKUST-1/ZnO/SA nanocomposite for Doxycycline and Naproxen adsorption from contaminated water.

Authors:  Lihua Xing; Kadhim Madjeed Haddao; Nafiseh Emami; Fereshteh Nalchifard; Woorod Hussain; Hadeer Jasem; Ashour H Dawood; Davood Toghraie; Maboud Hekmatifar
Journal:  Sustain Chem Pharm       Date:  2022-06-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.